Athens Research/Cambio - Excellence in Molecular Biology/10-3621-90

价格
面议
货号:10-3621-90
浏览量:46
品牌:Athens Research
服务
全国联保
正品保证
正规发票
签订合同
商品描述
Oligo Synthesis

Oligo Synthesis : CEPs

Prices quoted are for single packs only. For multiples of the same product please request a quote. Some of Glen"sproductsarehazardousandmay be subject to additional shipping charges. Full product information is available onGlen Research"s website.

  • Catalogue
  • Description
  • Protocols
  • Applications & Benefits

2"-OMe-iPr-Pac-G-CE Phosphoramidite

2"-OMe-iPr-Pac-G-CE Phosphoramidite

Glen Research

Catalogue No.DescriptionPack SizePriceQty
  • Change to:
  • €
10-3621-022"-OMe-iPr-Pac-G-CE Phosphoramidite0.25g£50.00£47.50Offer until : 31-Dec-2020Offer Code : GLEN55% off all Glen productsView OfferQuantityAdd to Order
10-3621-052"-OMe-iPr-Pac-G-CE Phosphoramidite0.5g£100.00£95.00Offer until : 31-Dec-2020Offer Code : GLEN55% off all Glen productsView OfferQuantityAdd to Order
10-3621-102"-OMe-iPr-Pac-G-CE Phosphoramidite1.0g£200.00£190.00Offer until : 31-Dec-2020Offer Code : GLEN55% off all Glen productsView OfferQuantityAdd to Order
10-3621-902"-OMe-iPr-Pac-G-CE Phosphoramidite100µmoles£30.00£28.50Offer until : 31-Dec-2020Offer Code : GLEN55% off all Glen productsView OfferQuantityAdd to Order

2"-OMe-iPr-Pac-G-CE Phosphoramidite

2"-OMe-iPr-Pac-G-CE Phosphoramidite

Glen Research

2"-OMe-iPr-Pac-G-CE Phosphoramidite

Structure

Catalog Number: 10-3621-xx

Description: 2"-OMe-iPr-Pac-G-CE Phosphoramidite

5"-Dimethoxytrityl-N2-isopropylphenoxyacetyl-Guanosine,2"-O-methyl,3"-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite
Formula: C52H62N7O10PM.W.: 976.07F.W.: 359.24

Diluent: Anhydrous Acetonitrile
Coupling: 6 minute coupling time.To avoid any exchange of the iPr-Pac group on the dG with acetyl, use the UltraMild Cap Mix A (40-4210-xx/ 40-4212-xx).
Deprotection: UltraMILD deprotection: 0.05M Potassium Carbonate in Methanol, 4 hours at Room Temperature OR 2 hours at Room Temperature in 30% Ammonium Hydroxide. Technical Bulletin
Storage: Freezer storage, -10 to -30°C, dry
Stability in Solution: 2-3 days

UltraMild 2’-OMe-RNA

The use of UltraMild monomers in oligonucleotide synthesis has allowed verysensitive dyes like TAMRA, HEX and Cy5 to be used virtually routinely. The DNAand RNA monomers are currently available and we also provide this set of2’-OMe-RNA monomers. In our version of this chemistry, we use as protectinggroups phenoxyacetyl (Pac) for A, acetyl (Ac) for C, and isopropyl-phenoxyacetyl(iPr-Pac) for G.

It has become clear that acetic anhydride in the conventional capping mix cancause transamidation in situations where an amine protecting group is quitelabile. This leads to acetyl protection on the amino group that may be slow tobe removed. Consequently, if many dG residues are included in theoligonucleotide, we recommend the use of phenoxyacetic anhydride (Pac2O) in CapA. This modification removes the possibility of exchange of the iPr-Pacprotecting group on the dG with acetate from the acetic anhydride capping mix

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

2"-OMe-iPr-Pac-G-CE Phosphoramidite

2"-OMe-iPr-Pac-G-CE Phosphoramidite

Glen Research

MSDS

Glen Report 15.1

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

2"-OMe-iPr-Pac-G-CE Phosphoramidite

2"-OMe-iPr-Pac-G-CE Phosphoramidite

Glen Research

BASES

DILUTION/COUPLING DATA

The table below shows pack size data and, for solutions, dilutions and approximate couplings based on normal priming procedures.

ABI 392/394
Cat.No.PackSizeGrams/Pack0.1M Dil.(mL)LV40LV20040nm0.2µm1µm10µm
Approximate Number of Additions
10-3621-020.25grams.25grams2.567243.22719.6414.43.6
10-3621-050.5grams.5grams5.12157.3394.45942.9131.477.87
10-3621-101.0gram1grams10.25328.33197123.1389.5565.6716.42
10-3621-90100µmoles.098grams120127.55.4541
Expedite
Cat.No.PackSizeGrams/PackDilution(mL)Molarity50nm0.2µm1µm15µm
Approximate Number of Additions
10-3621-020.25grams.25grams3.82.077043.7531.824.38
10-3621-050.5grams.5grams7.65.07146.691.6366.649.16
10-3621-101.0gram1grams15.29.07299.4187.13136.0918.71
10-3621-90100µmoles.098grams1.5.0723.614.7510.731.48
Beckman
Cat.No.PackSizeGrams/PackDilution(mL)Molarity30nm200nm1000nm
Approximate Number of Additions
10-3621-020.25grams.25grams3.82.0771.644.7532.55
10-3621-050.5grams.5grams7.65.07148.292.6367.36
10-3621-101.0gram1grams15.29.07301188.13136.82
10-3621-90100µmoles.098grams1.5.0725.215.7511.45

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

Myeloperoxidase Enzyme Immunoassay Kit 髓过氧化物酶 免疫分析试剂盒 Human MPO EIA KIT FEATURES: USE - Measure human MPO in a variety of matrices SAMPLE -Serum, Platelet-Poor Heparin Plasma, Saliva, Urine or Tissue Culture Media SAMPLES / KIT - 40 in duplicate SENSITIVITY - 0.068 ng/mL STABILITY - liquid reagents stable at 4°C QUICK RESULTS - 2.5 HOURS Myeloperoxidase (MPO) is a tetrameric heme-containing protein abundantly produced in neutrophil granulocytes where it plays an important anti-microbial role. During degranulation MPO is released into the extracellular space. There, as part of the neutrophils “respiratory burst”, it produces hypochlorous acid from hydrogen peroxide and Cl–. MPO also uses hydrogen peroxide to oxidize tyrosine to the tyrosyl radical. Both hypochlorous acid and tyrosyl are cytotoxic and when present can kill bacteria and other pathogens. Hereditary deficiency of myeloperoxidase predisposes individuals to immune deficiency. Studies have shown an association between elevated MPO levels and coronary artery disease, and in 2003 it was suggested that MPO may serve as a sensitive predictor of myocardial infarction in patients complaining of chest pain. Since that time the clinical utility of MPO testing in cardiac patients has been solidly established in the literature with well over 100 papers published. In 2010 this clinical application was further refined by additional studies which determined that measuring both MPO and C-reactive protein (CRP) provided more accurate prediction of mortality risk than measuring just CRP alone.